Comparison

PEPID® vs IV Medications Elsevier

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

PEPID®

Provides healthcare professionals with essential tools for patient care, including a vast drug database, medical calculators, and visual aids. Content is regularly updated and clinically independent, offering reliable information for various medical roles.

Highlights
  • Largest drug database
  • Medical calculators
  • High-res pill photos
  • Clinical illustrations
  • Regularly updated information
  • Independent clinical content
Features
Read full description

PEPID gives healthcare professionals all the tools they need to treat patients at the scene, en route and/or by the bedside. With just a few taps, access the largest drug database on the market, medical calculators, high-res pill photos, illustrations, and much more! -- Updated regularly, so you can be sure you have the most current information available -- Independent clinical content from 12 leading healthcare associations, including the American Academy of Emergency Medicine, American College of Emergency Physicians and the Family Physicians Inquiries Network -- Suites available for physicians, nurses, students, residents, pharmacists, EMTs and paramedics, and more Have questions, issues or feedback? Contact us at support@pepid.com.

About

IV Medications Elsevier

This comprehensive IV drug handbook provides nurses and health professionals with up-to-date information on over 400 intravenous drugs. It features quick-access monographs, highlighted warnings, and life-stage dosage variances to ensure safe and accurate medication administration.

Highlights
  • Over 400 IV drug monographs
  • New FDA-approved drug updates
  • Highlighted Black Box Warnings
  • Life stage dosage variances
  • Alphabetical drug format
  • Annual publication
Features
Read full description

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content. For nearly 50 years - #1 IV drug handbook to safely administer more than 400 intravenous drugs! Drug monographs for 10-20 newly approved drugs by the FDA include the most current information Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings. New to this edition - New drug monographs for approximately 10-20 newly approved drugs by the FDA provides readers with the most current drug information - Each monograph updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors Key Features - Annual publication prevents users from referencing outdated information - 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration - Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference - Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page - Highlighted Black Box Warnings and relevant content make locating critical information fast and easy - Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings - Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds - Dilution and dosage charts within monographs provide quick access to essential clinical information - Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients Content licensed from printed edition ISBN-10: 0443269599 Content licensed from printed edition ISBN-13: 9780443269592 SUBSCRIPTION : Please purchase a yearly auto-renewing subscription to receive content access and available updates. Yearly auto-renewing payments- $49.99 Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable. If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000 Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx Author(s):Shelly Rainforth Collins, PharmD Publisher:Elsevier Health Sciences

Screenshots

PEPID®3 screens
IV Medications Elsevier4 screens

Verdict

The call

The clearest difference is in-app purchases: PEPID® at none against IV Medications Elsevier's 8. PEPID® also leads on ads (none vs shown) and ratings volume (2.9K vs 72). IV Medications Elsevier's advantage is device support (4 vs 2) and iOS requirement (13.0 vs 15.6). On price and rating there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. IV Medications Elsevier sells 8 in-app purchases, starting at $25.99 per 3 months. PEPID® asks for nothing beyond the download.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 4.7 for PEPID® against 4.6 for IV Medications Elsevier. That said, the two scores are not equally well evidenced: PEPID® has 2.9K ratings behind it against 72, so its average is the more settled of the two. Written reviews are what separate them: 45% of PEPID®'s written reviews are positive against 33% of IV Medications Elsevier's.

UpkeepUpdate frequency

PEPID® ships an update every 5 weeks, IV Medications Elsevier every 5 months. The most recent releases landed on October 22, 2026 and October 24, 2026 respectively.

Scorecard8 real differences · 2 level
PEPID® versus IV Medications Elsevier: the parameters behind the verdict, then further details
ParameterPEPID®IV Medications Elsevier
PriceFreeFree
Rating4.7 (2.9K ratings) — better4.6 (72 ratings)
Positive reviews45.1% of reviews — better33.3% of reviews
Number of ratings2.9K — better72
Update frequencyEvery 5 weeks — betterEvery 5 months
AdsNo — betterYes
In-app purchasesNo — betterYes
MonetizationFree — betterFree with in-app purchases
DevicesiPhone, iPodiPhone, iPad, iPod, Mac — better
Requires iOS15.613.0 — better
Further details — not scored
Size39 MB149 MB
Age rating17+17+
DeveloperPEPID, LLCSkyscape Medpresso Inc

Customer experience

PEPID®

All ratings2,900 ratings
Positive94.3%
Neutral1.8%
Negative3.9%
Written reviews71 reviews
Positive45.1%
Neutral2.8%
Negative52.1%

IV Medications Elsevier

All ratings71 ratings
Positive93.0%
Neutral0.0%
Negative7.0%
Written reviews3 reviews
Positive33.3%
Neutral0.0%
Negative66.7%

Bugs and requests

PEPID®

Reported bugs

3 issues
  • App crashes on login or launch
  • Content fails to download
  • Incompatible with newer iOS versions

Requested features

4 requests
  • Improved search functionality
  • More calculators and tools
  • Automatic content updates
  • Ability to use on multiple devices with single subscription

IV Medications Elsevier

Not enough reviews yet to summarise bugs or requests.

In-app purchases

None

PEPID®

No in-app purchases

8 purchases

IV Medications Elsevier

Subscriptions7
  • Elsevier’s IV Med HBK 3/M Sub$25.993 Months
  • Elsevier’s IV Med HBK 6M Sub$32.996 Months
  • 25% Off-Elsevier IVMed 1Y Sub$37.491 Year
Show 4 more
  • Elsevier IV Med HBK 1Y Sub off$39.991 Year
  • 20% Off-Elsevier IVMed 1Y Sub$39.991 Year
  • 15% Off-Elsevier IVMed 1Y Sub$42.491 Year
  • Elsevier’s IV Med HBK 1Y Sub1 Month trial$49.991 Year
One-time1
  • Intravenous Medications 2022$49.99

Questions

Is PEPID® free?
PEPID® is free to download, with no in-app purchases.
Is IV Medications Elsevier free?
IV Medications Elsevier is free to download, with in-app purchases available.
Which has better reviews, PEPID® or IV Medications Elsevier?
PEPID® is rated higher. PEPID® averages 4.7 out of 5 from 2.9K ratings, while IV Medications Elsevier averages 4.6 from 72 ratings.
Do PEPID® or IV Medications Elsevier have ads?
IV Medications Elsevier shows ads; PEPID® does not.
Which is updated more often, PEPID® or IV Medications Elsevier?
PEPID® ships an update every 5 weeks, and IV Medications Elsevier every 5 months. Most recently, PEPID® was updated on October 22, 2026 and IV Medications Elsevier on October 24, 2026.

Other comparisons